Breaking News, Financial News

1Q Financial Reports: Cambrex

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

1Q Revenues: $119.8 million (+7%) 1Q Loss: $824,000 (net earnings of $4 million in 1Q2005) Comments: Contract biopharma sales rose 79% to $13.8 million, but $5.2 million was due to shipping inventory from a Phase III project cancelled in 4Q2005....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters